Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.25.0.1
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Feb. 12, 2025
Jun. 28, 2024
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Trading Symbol HLF    
Entity Registrant Name HERBALIFE LTD.    
Entity Central Index Key 0001180262    
Entity Current Reporting Status Yes    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Title of 12(b) Security Common Shares, par value $0.0005 per share    
Entity Shell Company false    
Security Exchange Name NYSE    
Entity Common Stock, Shares Outstanding   101,197,037  
Entity Public Float     $ 926
Entity File Number 1-32381    
Entity Incorporation, State or Country Code E9    
Entity Tax Identification Number 98-0377871    
Entity Address, Address Line One P.O. Box 309GT    
Entity Address, Address Line Two Ugland House, South Church Street    
Entity Address, City or Town Grand Cayman    
Entity Address, Country KY    
City Area Code 213    
Local Phone Number 745-0500    
Document Annual Report true    
Document Transition Report false    
Documents Incorporated by Reference

Portions of the registrant’s Definitive Proxy Statement to be filed with the Securities and Exchange Commission no later than 120 days after the end of the Registrant’s fiscal year ended December 31, 2024, are incorporated by reference in Part III of this Annual Report on Form 10-K.

    
ICFR Auditor Attestation Flag true    
Entity Address, Postal Zip Code KY1-1106    
Auditor Name PricewaterhouseCoopers LLP    
Auditor Location Los Angeles, California    
Auditor Firm ID 238    
Document Financial Statement Error Correction false    
Auditor Opinion [Text Block]

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Herbalife Ltd. and its subsidiaries (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of income, of comprehensive income, of changes in shareholders’ deficit and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company’s internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the COSO.